波科

Good health allows us to enjoy life, value our loved ones and pursue our passions. We are grateful for the chance to positively impact millions of patients worldwide.

The AMS 700? Inflatable Penile Prosthesis provides a long-term treatment option for erectile dysfunction – and its new TENACIO? Pump component is designed to help improve ease of use for patients. Learn how this groundbreaking innovation is helping people regain their sexual function. Visit https://bit.ly/4g5ckt8 for important risk information for the AMS 700 Inflatable Penile Prosthesis. https://bit.ly/4fUsuFQ

We’re excited to share that we have entered into a definitive agreement to acquire Intera Oncology Inc. , a medical device company that provides a solution to deliver hepatic artery infusion (HAI) therapy to patients with cancerous tumors that have metastasized to the liver. Upon close, we look forward to welcoming the Intera Oncology team to Boston Scientific and Boston Scientific Peripheral Interventions and are excited to add this complementary therapy, which will expand our offerings to treat both primary and metastatic forms of liver cancer. https://bit.ly/3Oq5a70

Writing for Forbes, our Chief Information and Digital Officer Jodi Euerle Eddy reflects on what it’s like to lead as a woman, why closing the leadership gap is good for business, and ways to help women succeed. Here are three key takeaways on how companies can help women grow into senior leaders: ??. ?????? ??????-???? ???????? ?????? ?????? ??: Successful inclusion initiatives require strong support and active participation from top leadership. Their day-to-day example will lead your company forward. ??. ???????????? ?? ?????????????????? ?????? ???????????????????? ?????? ?????????????????????? ??: Establish programs that connect women with mentors and advocates who can champion their growth and introduce them to new opportunities. ??. ???????????? ???? ?????????? ???????????????? ??: Employee-sponsored learning opportunities help unlock employees’ potential while also improving their job satisfaction and ensuring a diverse pipeline of leadership talent. Read more and see why we were named a 2024 Top Company for Executive Women by Seramount: https://bit.ly/3Z2Ylgy

Our Fostering Indigenous Resources and Empowerment (FIRE) employee resource group celebrates the rich cultures of people native to North America. In honor of #NativeAmericanHeritageMonth, we asked FIRE leaders to share why this time of year is especially meaningful.

We have successfully closed the acquisition of Axonics, Inc. We’re excited to add the company’s clinically differentiated devices to treat urinary and bowel dysfunction to the Boston Scientific Urology portfolio. Learn more here: https://bit.ly/3CvBjr8

The WaveWriter Alpha? SCS System, approved for the treatment of diabetic peripheral neuropathy (DPN) of the lower extremities, offers patients relief from nerve pain. #WorldDiabetesDay https://bit.ly/3YS8v3y

The completion of over 40 acquisitions and investment in R&D under the leadership of CEO and Chairman Mike Mahoney has helped position us as a leading medtech company, as noted by The Boston Globe. As we continue to grow, our commitment to improving patient lives remains central to our mission – a mission that fuels our innovation pipeline, our dedication to quality and our values-based culture. #AdvancingTogether https://bit.ly/3Z3WVDJ

We had the honor of ringing the closing bell at the NYSE to celebrate Boston Scientific’s 45th anniversary. This milestone is a tribute to our dedicated employees, the patients whose lives we’ve impacted, and the global communities we’ve served. Thank you to everyone who has contributed to our legacy over the past 45 years. Here’s to many more years #AdvancingTogether. Mike Mahoney, Nick Spadea-Anello, Charlie Attlan, Lance Bates, Vance Brown, Rosaleen Burke, Wendy Carruthers, Jodi Euerle Eddy, Mike Jones, Jeff Mirviss, Mary Beth Moynihan, Paudie O'Connor, Scott Olson, Meghan Scanlon, Ken Stein Photo by NYSE

We’re excited to announce that we have entered into a definitive agreement to acquire Cortex, a medical technology company focused on the development of a diagnostic mapping solution that may identify triggers and drivers outside the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder that impacts millions of people globally. Upon close, we look forward to advancing this technology and welcoming the Cortex team to Boston Scientific. https://bit.ly/3NTXVnS